Stem cell chief Dr. Maria Millan sheds light on CIRM’s future and potential 2020 bond – San Francisco Business Times
|
Stem cell chief Dr. Maria Millan sheds light on CIRM’s future and potential 2020 bond
San Francisco Business Times Eyes have been focused on the California Institute of Regenerative Medicine since California voters in 2004 approved Proposition 71, a $3 billion bond measure to speed research into stem cell therapies and help translate that research into treatments … |
pharmaphorum |
Scotland’s TC BioPharm joins bluebird to develop next-gen CAR–T
pharmaphorum US cancer biotech bluebird bio has joined with TC BioPharm in a collaboration focused on gamma delta CAR–T cells. As reported by pharmaphorum earlier this year, TC BioPharm has already won EU funding to develop its “off-the-shelf” chimeric antigen … |
CBS News |
DNA is going digital – what could possibly go wrong?
CBS News We’ve even hosted FBI agents from the Weapons of Mass Destruction Directorate here at Colorado State University and previously at Virginia Tech for crash courses on synthetic biology and the associated cyberbiosecurity risks. A year ago, we … |
Endpoints News |
Gilead swoops in with $567M deal to buy CAR–T 2.0 player Cell Design Labs
Endpoints News Gilead has swooped in on the first of several planned new buyouts to build out its CAR–T operations acquired in the $12 billion Kite buyout. And it’s starting with a company that Kite’s Arie Belldegrun believed held the key to the next-gen cell … Genetic Programmers Are the Next Startup MillionairesMIT Technology Review Gilead Sciences to Acquire Cell Design LabsGlobeNewswire (press release) Gilead to pop up to $567 million on East Bay ‘smart cell‘ startupSan Francisco Business Times Reuters –Business Wire (press release) –Nasdaq all 10 news articles » |